SEARCH

SEARCH BY CITATION

References

  • 1
    Abramson MJ, Puy RM, Weiner JM. Immunotherapy in asthma: an updated systematic review. Allergy 1999;54:10221041.
  • 2
    Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma (Cochrane review). In: Airways Group, eds. The Cochrane Library, Issue 2. 2005:153.
  • 3
    Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108(Suppl. 5):S147S334.
  • 4
    Bousquet J, Lockey RF, Malling H-J. WHO Position Paper Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53(Suppl.):142.
  • 5
    Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:412.
  • 6
    Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis (Cochrane review). In: Ear, Nose and Throat Disorders Group, eds. The Cochrane Library, Issue 1. 2005:119. Oxford, UK: Update software.
  • 7
    Olaguibel JM, Álvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergy in children: conclusions from one meta-analysis. J Investig Allergol Clin Immunol 2005;15:916.
  • 8
    Higgins JPT, Green S. editors Cochrane handbook for systematic reviews of interventions: 4.2.4. Monography on the Internet. Oxford, UK: The Cochrane Collaboration, 2005:265 (Available at: http://www.cochrane.org/resources/handbook/handbook.pdf, updated March 2005; accessed on April 20, 2005).
  • 9
    Pereira MG. Aferição dos eventos. In: PereiraMG, editor. Epidemiologia: teoria e prática. Rio de Janeiro: Guanabara Koogan, 1995:358376.
  • 10
    Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:112.
  • 11
    Limi A, Runyau A, Andersen V. RevMan [computer program on the Internet], Version 4.1. Kobeharvn: Nordic Cochrane Centre, 2005 (Available at: http://www.cc-ims.net/RevMan, accessed on April 20, 2005).
  • 12
    Bufe A, Ziegler-Kirbach E, Stoeckmann P, Heidemann P, Gehlhar K, Holand-Letz T et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004;59:498504.
  • 13
    Ippoliti F, De Santis W, Volterrani A, Lenti L, Canitano N, Lucarelli S et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003;14:216221.
  • 14
    Mauro M, Russelo M, Incorvaia C, D'Ingianna E, Gazzola G. Efficacy and safety of subcutaneous and sublingual immunotherapy in birch pollinosis. J Allergy Clin Immunol 2004; 113(Suppl. 2):S108.
  • 15
    Melaranci C, Matteoli MC. Efficacy of allergoid sublingual immunotherapy in children with asthma and/or allergic rhinoconjunctivitis: comparison study with drugs. J Allergy Clin Immunol 2004;113(Suppl. 2):S111.
  • 16
    Mungan D, Misirligil Z, Demirel YS, Gürbüz L. Efficacy of sublingual immunotherapy (SLIT) in mite sensitive patients with allergic rhinitis and asthma: a placebo controlled study. Eur Respir J Suppl 1996;9(Suppl. 23):210S.
  • 17
    Mungan D, Misirligil Z, Gürbüs L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma: a placebo controlled study. Ann Allergy Asthma Immunol 1999;82: 485490.
  • 18
    Orefice U. Efficacy of allergoid sublingual immunotherapy in patients with allergic bronchial asthma to house dust mite. J Allergy Clin Immunol 2004;113(Suppl. 2):S111.
  • 19
    Purello-D'Ambrosio F, Ricciardi L, Isola S, Puccinelli P, Musarra A. Rush sublingual immunotherapy in parietaria allergic patients. Allergol Immunopathol (Madr) 1996;24:146151.
  • 20
    Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite: a double-blind study. Allergol Immunopathol (Madr) 1990;18:277284.
  • 21
    Vourdas D, Syrigou E, Potamianou P, Carat F, Batard T, André C et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998;53:662672.
  • 22
    André C, Vatrinet C, Galvain S, Carat F, Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121:229234.
  • 23
    Arena A, Barbatano E, Gammeri E, Bruno M, Riva G. Specific immunotherapy of allergic diseases: a three years perspective observational study. Int J Immunopathol Pharmacol 2003;16:277282.
  • 24
    Bahçeciler NN, Arikan C, Taylor A, Akdis M, Blaser K, Barlan IB et al. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mite. Int Arch Allergy Immunol 2005;136:287294.
  • 25
    Di Rienzo V, Marcucci F, Puccinelli P, Parmiani S, Frati F, Sensi L et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003;33:206210.
  • 26
    Di Rienzo V, Minelli M, Musarra A, Sambugaro R, Pecora S, Canonica WG et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy 2005;35:560564.
  • 27
    Feliziani V, Marfisi RM, Parmiani S. Rush immunotherapy with sublingual administration of grass allergen extract. Allergol Immunopathol (Madr) 1993;21:173178.
  • 28
    Gozalo F, Martin S, Rico P, Álvarez E, Cortes C. Clinical efficacy and tolerance of two year Lolium perenne sublingual immunotherapy. Allergol Immunopathol (Madr) 1997;25:219227.
  • 29
    Lombardi C, Gargioni S, Venturini S, Zoccali P, Canonica GW, Passalacqua G. Controlled study of preseasonal immunotherapy with grass pollen extract in tablets: effect on bronchial hyperreactivity. J Investig Allergol Clin Immunol 2001;11:4145.
  • 30
    Marogna M, Massolo A. Sublingual immunotherapy in the context of a clinical practice improvement program in the allergological setting: results of a long-term observational study. Allerg Immunol (Paris) 2003;35:133140.
  • 31
    Mitsch A, Drachenberg KJ. Positive Ergebnisse einer ersten multizentrischen Untersuchung: spezifische Immuntherapie sublingual applizierbar. TW Pädiatr 1996;9:628631.
  • 32
    Pajno GB. Allergen immunotherapy in early childhood: between Scylla and Charybdis! Clin Exp Allergy 2005;35:551553.
  • 33
    Sanchez Palacios A, Schamann F, Garcia JA. Inmunoterapia sublingual com extracto de epitélio de gato: experiência personal. Allergol Immunopathol (Madr) 2001;29:6065.
  • 34
    Rakoski J, Wessner D. A short assessment of sublingual immunotherapy. Int Arch Allergy Immunol 2001;126:185187.
  • 35
    Silvestri M, Spallarossa D, Battistini E, Sabatini F, Pecora S, Parmiani S et al. Changes in inflammatory and clinical parameters and in bronchial hyperreactivity in asthmatic children sensitized to house dust mites following sublingual immunotherapy. J Investig Allergol Clin Immunol 2002;12:5259.
  • 36
    Wüthrich B, Bucher Ch, Jörg W, Bircher A, Schneider Y, Schnyder F et al. Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen. J Investig Allergol Clin Immunol 2003;13:145148.
  • 37
    André C, Perrin-Fayolle M, Grosclaude M, Coutuier P, Basset D, Cornillon J et al. A double-blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis: evidence for a dose-response relationship. Int Arch Allergy Immunol 2003;131:111118.
  • 38
    Bowen T, Greenbaum J, Charbonneau Y, Hebert J, Filderman R, Sussman G et al. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis. Ann Allergy Asthma Immunol 2004;93:425430.
  • 39
    Clavel R, Bousquet J, André C. Clinical efficacy of sublingual swallow immunotherapy: a double blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998;53:493498.
  • 40
    Scheinmann P, President. Symposium Satellite Stallergènes – DHS, 11 janvier 2002: Du protocole thérapeutique à la démonstration clinique: les atouts de la voie sublinguale. Allerg Immunol (Paris) 2002;34:6062.
  • 41
    Horak F, Stübner P, Berger UE, Marks B, Toth J, Jäger S. Immunotherapy with sublingual birch pollen extract: a short-term double-blind placebo study. J Investig Allergol Clin Immunol 1998;8:165171.
  • 42
    Hordijk GJ, Antvelink JB, Luwema RA. Sublingual immunotherapy with a standardized grass pollen extract; a double-blind placebo-controlled study. Allergol Immunopathol (Madr) 1998;26:234240.
  • 43
    Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H. A double blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309313.
  • 44
    Vervloet D, Bimbaum J, Laurent P, Hugues B, Fardeau MF, Massabie-Bouchat YP et al. Safety and clinical efficacy of rush sublingual cypress immunotherapy: preliminary results. Allergy 2002;57(Suppl. 70):70.
  • 45
    Cirla AM, Cirla PE, Parmiani S, Pecora S. A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals: a case-referent, two-year controlled study. Allergol Immunopathol (Madr) 2003;31:3143.
  • 46
    Crimi E, Voltolini S, Troise C, Gianiorio P, Crimi P, Brusasco V et al. Local immunotherapy with Dermatophagoides extract in asthma. J Allergy Clin Immunol 1991;87:721728.
  • 47
    Quirino T, Iemoli E, Siciliani E, Parmiani S, Milazzo F. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double-blind (double dummy) study. Clin Exp Allergy 1996;26:12531261.
  • 48
    TePas EC, Hoyte EG, McIntere JJ, Umetsu DT. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals. Ann Allergy Asthma Immunol 2004;92:2531.
  • 49
    Almagro E, Asensio O, Bartolomé JM, Bosque M, De La Hoz B, Dolz I et al. Estúdio multicéntrico de farmacovigilancia de inmunoterapia sublingual en pacientes alérgicos. Allergol Immunopathol (Madr) 1995;23:153159.
  • 50
    Grosclaude M, Bouillot P, Alt R, Leynadier F, Scheinmann P, Rufin P et al. Safety of various dosage regimens during induction of sublingual immunotherapy: a preliminary study. Int Arch Allergy Immunol 2002;129:248253.
  • 51
    Tari MG, Mancino M, Madonna F, Buzzoni L, Parmiani S. Immunologic evaluation of 24 month course of sublingual immunotherapy. Allergol Immunopathol (Madr) 1994;22:209216.
  • 52
    Ariano R, Spadolini I, Panzani RC. Efficacy of sublingual specific immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica: a double blind study. Allergol Immunopathol (Madr) 2001;29:238244.
  • 53
    Ariano R, Panzani RC, Mistrello G. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy: preliminary data. Allerg Immunol (Paris) 2005;37:103108.
  • 54
    Bahçeciler NN, Isik U, Barlan IB, Basaran MM. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 2001;32:4955.
  • 55
    Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999;54:249260.
  • 56
    Drachenberg KJ, Pfeiffer P, Urban E. Sublingual immunotherapy: results from a multi-centre, randomised, double-blind, placebo-controlled study with a standardised birch and grass/rye pollen extract. Allergologie 2001;24:525534.
  • 57
    Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts: a double blind study. Allergol Immunopathol (Madr) 1995;23:224230.
  • 58
    Hirsch T, Sähn M, Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children. Pediatr Allergy Immunol 1997;8:2127.
  • 59
    Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 2004;59:12051210.
  • 60
    Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study. J Allergy Clin Immunol 2005;115:11841188.
  • 61
    Niu C, Wang J, Huang J, Lue K, Chen W. Efficacy and safety of sublingual immunotherapy with high dose house dust mite extract in asthmatic children: a multicenter randomized double-blind, and placebo-controlled study. J Allergy Clin Immunol 2004;113(Suppl. 2):S108.
  • 62
    Novembre E, Marano E, Bernardini R. Sublingual immunotherapy in the treatment of allergic asthma in children: a controlled study. Riv Ital Pediatr (IJP) 1991;17:7578.
  • 63
    Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004;114:851857.
  • 64
    Pajno GB, Morabito L, Barberio G, Parmiani S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 2000;55:842849.
  • 65
    Pajno GB, Vita D, Parmiani S, Caminiti L, La Gruta S, Barberio G. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to parietaria pollen treated with inhaled fluticasone propionate. Clin Exp Allergy 2003;33:16411647.
  • 66
    Pajno GB, Passalacqua G, Vita D, Caminiti L, Parmiani S, Barberio G. Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with parietaria-induced respiratory allergy: a randomized controlled trial. Allergy 2004;59:883887.
  • 67
    Passalacqua G, Albano M, Fregonese L, Riccio A, Pronzato C, Mela GS et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629632.
  • 68
    Passalacqua G, Albano M, Riccio A, Fregonese L, Puccinelli P, Parmiani S et al. Clinical and immunologic effects of a rush sublingual immunotherapy to parietaria species: a double blind, placebo-controlled trial. J Allergy Clin Immunol 1999;104:964968.
  • 69
    Patriarca G, Nucera E, Pollastrini E, Roncallo C, Buonomo A, Bartolozzi F et al. Sublingual desensitization: a new approach to latex allergy problem. Anesth Analg 2002;95:956960.
  • 70
    Pradalier A, Basset D, Claudel A, Couturier P, Wessel F, Galvain S et al. Sublingual swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999;54:819828.
  • 71
    Purello-D'Ambrosio F, Gangemi S, Isola S, La Motta N, Puccinelli P, Parmiani S et al. Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both. Allergy 1999;54:968973.
  • 72
    Rodriguez Santos O. Inmunoterapia sublingual con extracto alergenico de Dermatophagoides pteronissinus en ninos com asma. Rev Alerg Mex 2004;51:177180.
  • 73
    Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lane J, Kopp MV et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004;59:12851293.
  • 74
    Sambugaro R, Puccinelli P, Burastero SE, Di Rienzo V. The efficacy of sublingual immunotherapy for respiratory allergy is not affected by different dosage regimens in the induction phase. Allergol Immunopathol (Madr) 2003;31:329337.
  • 75
    Voltolini S, Modena P, Minale P, Bignardi D, Troise C, Puccinelli P et al. Sublingual immunotherapy in tree pollen allergy: double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule. Allergol Immunopathol (Madr) 2001;29:103110.
  • 76
    Yuksel H, Tanac R, Gousseinov A, Demir E. Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy. J Investig Allergol Clin Immunol 1999;9:305313.
  • 77
    Di Rienzo V, Pagani A, Parmiani S, Passalacqua G, Canonica GW. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999;54:11101113.
  • 78
    Malling H-J. Allergen immunotherapy efficacy in rhinitis and asthma. Allergy Clin Immunol Int J World Allergy Org 2004;16:9295.
  • 79
    Passalacqua G, Guerra L, Pasquali M, Lombardi C, Canonica GW. Efficacy and safety of sublingual immunotherapy. Ann Allergy Asthma Immunol 2004;93:312.
  • 80
    Passalacqua G, Lombardi C, Canonica GW. Sublingual immunotherapy: an update. Curr Opin Allergy Clin Immunol 2004;4:3136.
  • 81
    Passalacqua G, Guerra L, Fummagali F, Compalati E, Canônica GW. An update on sublingual immunotherapy. Allergy Clin Immunol Int J World Allergy Org 2005;17:181185.
  • 82
    Sopo SM, Macchiaiolo M, Zorzi G, Tripodi S. Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature. Arch Dis Child 2004;89:620624.
  • 83
    Wessner D, Rakoski G, Ring J. Efficacy of sublingual immunotherapy in grass pollen allergy. Chem Immunol Allergy 2003;82:5361.
  • 84
    Begg C, Cho M, Eastwood S, Horton R, Moher D, Alkin I et al. Improving the quality of reporting of randomised controlled trials: the CONSORT statement. JAMA 1996;276:637639.
  • 85
    Akdis CA, Blaser K. Mechanisms of allergen-specific immunotherapy. Allergy 2000;55:522530.
  • 86
    Bellinghausen I, Knop J, Saloga J. Role of interleukin 10-producing T cells in specific (allergen) immunotherapy. Allergy Clin Immunol Int J World Allergy Org 2000;12:2025.